Combined Training on Body Composition of Postmenopausal Women Undergoing Treatment for Breast Cancer
Effectiveness of Physical Training on Body Composition, Physical Activity Level and Quality of Life of Postmenopausal Women Undergoing Treatment for Breast Cancer With Aromatase Inhibitors: The Randomized Clinical Trial.
1 other identifier
interventional
83
0 countries
N/A
Brief Summary
Breast cancer is a multifactorial disease affecting women, and one of the treatments for its healing and survival is hormone therapy. Aromatase inhibitors are third-generation drugs that promote lower chance of metastasis, but their side effects include the loss of bone mineral density and increased fat percentage. In this way, the Combined Training (combined resistance and endurance training) may be an interesting strategy to minimize the side effects of aromatase inhibitors, providing better quality of life, survival and changes in body composition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Aug 2015
Shorter than P25 for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 10, 2016
CompletedFirst Posted
Study publicly available on registry
June 17, 2016
CompletedJune 17, 2016
March 1, 2015
10 months
June 10, 2016
June 16, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chance from Body composition at 9 months assessment by bone densitometry (Dual-energy x-ray absorptiometry), using the equipment model GE Lunar - DPX-NT
At baseline, 3, 6 and 9 months timepoint
Secondary Outcomes (14)
Quality of life assessed via the questionnaire EORTC (European Organization for Research and Treatment of Cancer Quality of Life Questionnarie).
At baseline, 3, 6 and 9 months timepoint
Bone mineral density (total, spine and femur) in these participants by bone densitometry (Dual-energy x-ray absorptiometry), using the equipment model GE Lunar - DPX-NT.
At baseline, 3, 6 and 9 months timepoint
Serum levels of glucose in these participants measured by enzymatic colorimetric kit processed in Autohumalyzer A5
At baseline, 3, 6 and 9 months timepoint
Serum levels of C-reactive protein (CRP) in these participants measured by enzymatic colorimetric kit processed in Autohumalyzer A5
At baseline, 3, 6 and 9 months timepoint
Serum levels of total cholesterol and fractions in these participants measured by enzymatic colorimetric kit processed in Autohumalyzer A5.
At baseline, 3, 6 and 9 months timepoint
- +9 more secondary outcomes
Study Arms (2)
Group Control with breast cancer and without breast cancer
NO INTERVENTIONStretching exercises, lasting 40 minutes each session, 2 times a week for nine months
Combined Training with breast cancer and without breast cancer
EXPERIMENTALCombined Training: 36 weeks duration, 3 times a week on nonconsecutive days. The combined training program lasts 70 minutes per session, with 40 minutes of resistance training and 30 minutes of aerobic training.
Interventions
Eligibility Criteria
You may qualify if:
- Postmenopausal, defined by the absence of periods for the past 12 months;
- Breast cancer diagnosis stages 1 to 3;
- The adjuvant treatment for breast cancer and / or neoadjuvant aromatase inhibitors
- No abnormalities on screening physical or any health problems that contraindicate study participation;
- No contraindications for treadmill testing or entry into a training program, including any of the following:
- Myocardial infarction within the past 6 months
- Pulmonary edema
- Myocarditis Pericarditis
- Unstable angina
- Pulmonary embolism or deep vein thrombosis
- Uncontrolled hypertension (i.e., blood pressure \> 200/100 mm Hg)
- Uncontrolled arrhythmia
- No significant mental illness
- Have medical certificate to perform exercise testing and participate in combined training
- Able to answer Questionnaires
- +3 more criteria
You may not qualify if:
- Accumulating 3 unexcused absences or 4 consecutive unexcused absences during the month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Felipe J, Viezel J, Reis AD, da Costa Barros EA, de Paulo TRS, Neves LM, Junior IFF. Relationship of different intensities of physical activity and quality of life in postmenopausal women. Health Qual Life Outcomes. 2020 May 6;18(1):123. doi: 10.1186/s12955-020-01377-1.
PMID: 32375779DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ismael F Freitas Junior, Doctor
UPECLIN HC FM Botucatu Unesp
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- masters degree
Study Record Dates
First Submitted
June 10, 2016
First Posted
June 17, 2016
Study Start
August 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 17, 2016
Record last verified: 2015-03